A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis

NCT04673786 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: CT-P43
BIOLOGICAL: Stelara

Sponsor

Celltrion